Document Detail

Sustained release characteristics of rifampin-loaded microsphere formulations in nonhuman primates.
MedLine Citation:
PMID:  15371105     Owner:  NLM     Status:  MEDLINE    
Controlled release rifampin-loaded microspheres were evaluated for the first time in nonhuman primates. Animals received either 2.0 g of a large formulation (10-150 microm, 23 wt% rifampin) injected subcutaneously at Day 0 (118-139 mg rifampin/kg), 4.0 g of a small formulation (1-10 microm, 5.8 wt% rifampin) administered intravenously in 2.0 g doses on Day 0 and 7 (62.7-72.5 mg rifampin/kg), or a combination of small and large microspheres (169-210 mg rifampin/kg). Extended rifampin release was observed up to 48 days. Average rifampin concentrations remaining in the liver, lung, and spleen at 30 days were 14.03, 4.09, and 1.98 microg/g tissue, respectively.
Debra Quenelle; Gary A Winchester; Jay K Staas; Darrel E Hoskins; Esther W Barrow; William W Barrow
Related Documents :
10604045 - Comparative bioavailability of two different diclofenac formulations in healthy volunte...
3243175 - Comparative human bioavailability study of macrocrystalline nitrofurantoin and two prol...
1820875 - Linearity of levodropropizine, a new antitussive drug, in the healthy volunteer.
18672975 - Pharmacokinetics after administration of an injectable experimental long-acting parente...
3099865 - The effect of pretreatment with thio-tepa and cytosine arabinoside on megakaryocytopoie...
21281215 - Efficacy of oral transmucosal and intravenous administration of buprenorphine before su...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Drug delivery     Volume:  11     ISSN:  1071-7544     ISO Abbreviation:  Drug Deliv     Publication Date:    2004 Jul-Aug
Date Detail:
Created Date:  2004-09-16     Completed Date:  2005-01-25     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9417471     Medline TA:  Drug Deliv     Country:  England    
Other Details:
Languages:  eng     Pagination:  239-46     Citation Subset:  IM    
Department of Pediatrics, Division of Infectious Diseases, University of Alabama at Birmingham, Alabama, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chemistry, Pharmaceutical
Delayed-Action Preparations / administration & dosage,  chemistry,  pharmacokinetics
Macaca fascicularis
Rifampin / administration & dosage,  chemistry*,  pharmacokinetics*
Grant Support
Reg. No./Substance:
0/Delayed-Action Preparations; 13292-46-1/Rifampin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in ...
Next Document:  Development of liposomal amphotericin B dry powder inhaler formulation.